The current arrangement builds on an existing agreement signed last year that allowed Garvan to use DNAnexus' platform for its genomics activities.
The tool, which allows conventional searching of data-independent acquisition mass spec data, previously worked only with AB Sciex TripleTOF instruments.
E-Nios spun out from the National Hellenic Research Foundation in 2013 to commercialize computational methods for identifying and prioritizing gene targets.
Internal benchmarks from the company show that the new technology, to be released next month, predicts variant pathogenicity with 98 percent accuracy.
The company was established earlier this year by the co-founders of reproductive genetics firm Recombine, which was sold to CooperSurgical in May.
Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.
In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.
South African researchers uncover bone cancer in an ancient hominin ancestor.
English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.